The biopharma industry is at a crossroads: rising costs and regulatory complexity demand new approaches to efficiency. For research teams and executives alike, the imperative is clear — strengthen supply chains, rethink sourcing strategies, and adopt smarter innovation models.

At DKSH Performance Materials, we believe that connecting businesses with the right solutions should be fast, smart, and seamless. We are thrilled to share that our digital customer platform, DKSH Discover, has been recognized for doing just that by winning two prestigious awards at the Marketing Interactive Asia E-Commerce Awards 2025.

Analysts forecast oncology mRNA will be a multi-billion-dollar market by 2030. The winners won’t just have the best science — they’ll have supply chains that regulators, clinicians, and payers trust.

We’re bringing innovation to Paris this December! Visit us at Booth 40D50 to discover what’s next in food ingredients. Stay tuned—something exciting is cooking.

Bioprocessing leaders today face mounting pressure: how to accelerate development, secure yields, and ensure compliance in a cost-sensitive, highly regulated market. The right ingredients are no longer a commodity purchase — they are the strategic backbone of speed, yield, and regulatory success. Here are the Top Bioprocessing Pressures and how DKSH’s ingredient portfolio directly addresses them!

As cell and gene therapies revolutionize treatment for cancer, rare diseases, and immunological disorders, DKSH is committed to supporting researchers and manufacturers with a specialized product range that meets the evolving demands of this dynamic field.

When it comes to skincare, Vitamin C is one of the most popular and trusted ingredients. From brightening dark spots, reducing wrinkles and boosting collagen, it has earned its place as a gold standard in dermatology and cosmetic science. But here is the challenge, not all Vitamin C is stable or gentle. Pure ascorbic acid can oxidize quickly and often causes irritation or is too harsh when used at high concentrations. Thats where AA2G™ (Ascorbyl Glucoside), developed by Nagase Viita.

Mini DuoCol® 2% Solution was developed by Trautec, a U.S. biotech innovator holding exclusive IP in recombinant collagen, in collaboration with the DKSH North America Innovation Center. Their breakthrough wasn’t just producing collagen through fermentation, it was making it scalable, high-purity, and fully compatible with human skin. Today, DKSH brings this breakthrough to market with exclusive global distribution of Mini DuoCol® 2% Solution.

Fat alternatives that align with the “natural” and “healthy indulgence” trends are no longer optional—they're essential. Enter Campus Replifat PH Plus/Replifat TH, a next-generation fat replacer tailored for processed meat applications.

What happens when a cosmetic chemist gets tired of endless spreadsheets, scattered data, and outdated systems? Instead of settling, they build what the market has been missing. That’s the story behind KosmetikOn, a digital platform designed not in a boardroom, but by people who understand what really slows R&D teams down.

The global nutraceutical market continues to evolve as consumers become increasingly health-conscious, seeking preventive solutions for gut, immunity, and metabolic wellness. Science-backed bioactives have gained significant attention for their ability to naturally support vital bodily functions while promoting overall wellbeing.

Demand for clinically supported, multifunctional nutraceuticals that address skin health, cognitive function, vitality, and joint care is steadily increasing. Bioavailable, high-purity actives are now key drivers in supplement innovations targeting proactive aging and wellness.